Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes

OBJECTIVE: Iguratimod, a novel disease-modifying anti-rheumatic drug for the treatment of rheumatoid arthritis, has been approved in China and Japan. Here, we aimed to find whether iguratimod can inhibit the aggressive behavior and promote apoptosis of rheumatoid fibroblast-like synoviocytes (RA-FLS...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Immunol Res
मुख्य लेखकों: Lin, Jin, Yu, Ye, Wang, Xuanwei, Ke, Yini, Sun, Chuanyin, Yue, Lihuan, Xu, Guanhua, Xu, Bei, Xu, Liqin, Cao, Heng, Xu, Danyi, Olsen, Nancy, Chen, Weiqian
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Hindawi 2019
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885276/
https://ncbi.nlm.nih.gov/pubmed/31828173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6929286
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन